Results 211 to 220 of about 434,444 (268)

Rewriting Tumor Immunity With Bacterial Membrane Vesicles: A Versatile and Potent Therapeutic Strategy

Advanced NanoBiomed Research, EarlyView.
Bacterial membrane vesicles (BMVs) emerge as promising platforms for cancer immunotherapy owing to their intrinsic adjuvant properties and tunable cargo delivery capabilities. Their ability to modulate the tumor microenvironment, enhance antitumor immune responses, and support personalized therapeutic strategies highlights their growing potential as ...
Md Sifat Rahi, Md Mijanur Rahman, Asma Talukder, Urooj Yousaf Virk, Jennifer C. Wilson, Nigel McMillan, Ming Q. Wei   +6 more
wiley   +1 more source

Advanced Glycation End-Products Contribute to Delayed Diabetic Corneal Epithelial Wound Healing via the TLR4 Signaling. [PDF]

Invest Ophthalmol Vis Sci
Yu Y, Zhang Y, Tang Y, Ma L, Wei C, Bai X.   +5 more
europepmc   +1 more source

Higher serum zinc micronutrient levels are associated with reduced susceptibility to Group B Streptococcus rectovaginal colonisation in pregnant women. [PDF]

PLoS One
Dhar N, Gaddy J, Aronoff DM, Channa K, Madhi SA, Kwatra G.   +5 more
europepmc   +1 more source

AI-Powered Resting 12-Lead Electrocardiogram Algorithm for Predicting Low Peak Oxygen Consumption: Development and Validation Study. [PDF]

JMIR Med Inform
Huang SC, Fu TC, Liou M, Huang YC, Chang SY, Huang GY, Su HR, Su HR.   +7 more
europepmc   +1 more source

Untersuchung von Anti‐Glykan‐Antikörpern und Erforschung ihres medizinischen Potenzials mithilfe synthetischer Glykane

Angewandte Chemie, EarlyView.
Anti‐Glykan‐Antikörper spielen sowohl bei Gesundheit als auch bei Krankheit eine wesentliche Rolle. Der Zugang zu neuartigen Glykanstrukturen ermöglicht Fortschritte bei der Antikörpercharakterisierung für die Entdeckung von Biomarkern, die Antikörperentwicklung und das Impfstoffdesign.
Fabienne Weber, Aina Valenti, Jiří Ledvinka, Oren Moscovitz, Peter H. Seeberger   +4 more
wiley   +1 more source

Identification of immunomodulators associated with atrial fibrillation reporting to better understand AF immunologic mechanisms: a Vigibase retrospective disproportionality analysis and a literature review. [PDF]

BMJ Open
Font J, Dolladille C, Divoux J, Chretien B, de Boysson H, Legallois D, Ollitrault P, Champ-Rigot L, Ferchaud V, Pellissier A, Milliez P, Alexandre J.   +11 more
europepmc   +1 more source

Correction to "2D Quantum Spin-Liquid Candidate Including a Chiral Anion: κ-(BEDT-TTF)₂[B_{<i>R</i>/<i>S</i>}(salicylate)₂]". [PDF]

J Am Chem Soc
Blundell TJ, Sneade K, Ogar JO, Yamashita S, Akutsu H, Nakazawa Y, Yamamoto T, Martin L.   +7 more
europepmc   +1 more source

Unmet health care needs in immune thrombotic thrombocytopenic purpura survivors. [PDF]

Res Pract Thromb Haemost
Story CM, Brown J, Martin C, Chaturvedi S.   +3 more
europepmc   +1 more source

Using Synthetic Glycans to Investigate Anti‐Glycan Antibodies and Explore Their Medical Potential

Angewandte Chemie International Edition, EarlyView.
Anti‐glycan antibodies are essential in health and disease. Access to novel glycan structures paves the way for progress in antibody profiling for biomarker discovery, antibody development, and vaccine design. We summarize the strategies to synthesize and utilize synthetic glycans for the development and application of anti‐glycan antibodies in basic ...
Fabienne Weber, Aina Valenti, Jiří Ledvinka, Oren Moscovitz, Peter H. Seeberger   +4 more
wiley   +1 more source